{{knowledge objective
|Identifiant=OIC-177-08-B
|Item_parent=Prescription and monitoring of anti-infectives in adults and children (see item 330)
|Item_parent_short=Prescription and monitoring of anti-infectives in adults and children (see item 330)
|Rank=B
|Heading=Know (indications, contraindications, spectrum, side effects and interactions) the main molecules belonging to the third generation injectable cephalosporins.
|Description=Ceftriaxone, cefotaxime
|Rubric=Definition
|Contributors=Jean-Philippe Lavigne
|Order=8}}

{| class="wikitable"
|'''Antibiotics'''
|'''Indications'''
|'''Contraindications'''
|'''Spectrum'''
|'''Side effects and interactions'''
|-
|'''Cephalosporins of 3rd<sup>th</sup> generation for injection (molecules: ceftriaxone, cefotaxime, ceftazidime, cefepime)''''
|Purulent meningitis (probabilistic), severe forms of localised or systemic Gram-negative bacillus infections, extra-pulmonary pneumococcal infections (meningitis) with reduced susceptibility to penicillin, fever in neutropenic patients, pyelonephritis and male urinary tract infections, nosocomial infections, secondary and tertiary Lyme disease, typhoid fever, etc.
|Hypersensitivity to the active substance or to one of the excipients, history of severe hypersensitivity to any beta-lactam antibacterial.
|<Ceftriaxone, cefotaxime: Streptococci (including pneumococci), Neisseria spp., Enterobacteriaceae (unless acquired resistance), Haemophilus spp.

-Ceftazidime and cefepime: ''P. aeruginosa,'' enterobacteria with certain resistances (cephalosporinases)
|Allergic reactions,

More rarely: leukopenia, neutropenia, eosinophilia, neurotoxicity, diarrhoea, increased liver enzymes


Interactions: probenecid, aminoglycosides, furosemide
|}